Coming Soon

« Company Overview
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
9,393
2020-02-01 to 2020-12-31
Collaborative R&D
Awaiting Public Project Summary
153,536
2017-04-01 to 2019-09-30
Collaborative R&D
Exceptional electronic properties, surface sensitivity and selectivity, make graphene ideal for sensor applications. Novel, generic, real-time monitoring sensor technology, based on chemically modified graphene channels, will be demonstrated for the detection of salivary / serum hepatitis biomakers. The project will develop an innovative graphene based point-of-care sensor platform for the early detection of multiple hepatitis biomarkers, for simultaneous monitoring of hepatitis A, B and C. The generic POC platform will enable more efficient & effective healthcare delivery and improved health outcomes for patients. Graphene sensors will be fabricated on full wafers and functionalised using a novel chemical and biochemical modification techniques. Graphene sensor devices will be integrated with printed electronics and microfluidics to form a self contained packaged, single-use sensor. The sensor platform can also be adapted for the detection of other disease markers including, stroke, heart disease, cancer and dementia. A complete disposable strip and electronic reader system, akin to blood glucose monitoring kits, will be developed.
53,782
2015-03-01 to 2017-05-31
Collaborative R&D
The project will develop an innovative Silicon Nanowire (SiNW) based point-of-care multiplex sensor platform for the early detection of multiple disease biomarkers simultaneously, for the monitoring of chronic conditions. The generic POC platform will enable more efficient & effective healthcare delivery and improved health outcomes for patients. SiNW sensors will be fabricated on full wafers and functionalised using a novel multi-electrode array. The first SiNW immunosensors will detect the hormone cortisol for the fertility market. Multiplex sensors will detect serotonin and noradrenelin in addition to cortisol. SiNW sensor devices will be integrated with printed electronics to form a self contained packaged, single-use sensor. The sensor platform can be adapted for the detection of other disease markers including, stroke, heart disease, cancer and dementia. A complete disposable strip and electronic reader system, akin to blood glucose monitoring kits, will be developed.